M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B
暂无分享,去创建一个
Kapil Khatri | N. Mishra | A. Goyal | S. Vyas | Prem N. Gupta | Prem N Gupta | Suresh P Vyas | Neeraj Mishra | K. Khatri | Amit K Goyal
[1] I. M. Belyakov,et al. Strategies for designing and optimizing new generation vaccines , 2001, Nature Reviews Immunology.
[2] E. Untersmayr,et al. Functionalisation of allergen-loaded microspheres with wheat germ agglutinin for targeting enterocytes. , 2004, Biochemical and biophysical research communications.
[3] A. Nakane,et al. Endogenous tumor necrosis factor, interleukin-6, and gamma interferon levels during Listeria monocytogenes infection in mice , 1992, Infection and immunity.
[4] K. Griebenow,et al. Improved activity and stability of lysozyme at the water/CH2CI2 interface: enzyme unfolding and aggregation and its prevention by polyols , 2001, The Journal of pharmacy and pharmacology.
[5] S. Sahoo,et al. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[6] A. Jones,et al. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. , 1996, Pharmaceutical research.
[7] M. Isaka,et al. Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant. , 2001, Vaccine.
[8] S. Schwendeman,et al. Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.
[9] E. Lavelle,et al. Immunological Implications of the use of Plant Lectins for Drug and Vaccine Targeting to the Gastrointestinal Tract , 2004, Journal of drug targeting.
[10] J L Pedraz,et al. Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres. , 2002, Vaccine.
[11] J. Cleland,et al. Stable Formulations of Recombinant Human Growth Hormone and Interferon-γ for Microencapsulation in Biodegradable Mircospheres , 1996, Pharmaceutical Research.
[12] I. Ezpeleta,et al. Preparation of lectin-vicilin nanoparticle conjugates using the carbodiimide coupling technique , 1996 .
[13] B. Hirst,et al. Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo. , 1998, Vaccine.
[14] E. Untersmayr,et al. Mucosal targeting of allergen-loaded microspheres by Aleuria aurantia lectin. , 2005, Vaccine.
[15] S. Vyas,et al. Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting. , 2001, Critical reviews in therapeutic drug carrier systems.
[16] M. Wirth,et al. Lectin-mediated bioadhesion: binding characteristics of plant lectins on the enterocyte-like cell lines Caco-2, HT-29 and HCT-8. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[17] O’Hagan,et al. Microparticles and polymers for the mucosal delivery of vaccines. , 1998, Advanced drug delivery reviews.
[18] D. Prabakaran,et al. Development of a single‐dose stabilized poly(d,l‐lactic‐co‐glycolic acid) microspheres‐based vaccine against hepatitis B , 2004, The Journal of pharmacy and pharmacology.
[19] G. Ponchel,et al. Covalent coupling of asparagus pea and tomato lectins to poly(lactide) microspheres. , 2001, International journal of pharmaceutics.
[20] F. Brodsky,et al. The cell biology of antigen processing and presentation. , 1991, Annual review of immunology.
[21] S. Vyas,et al. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. , 2006, Vaccine.
[22] Robert Langer,et al. Lectin-bearing Polymerized Liposomes as Potential Oral Vaccine Carriers , 1996, Pharmaceutical Research.
[23] M. Wirth,et al. Lectin-Mediated Bioadhesion: Preparation, Stability and Caco-2 Binding of Wheat Germ Agglutinin-Functionalized Poly(D,L-lactic-co-glycolic acid)-Microspheres , 2000, Journal of drug targeting.
[24] J. Benoit,et al. Surface characterization of poly(alpha-hydroxy acid) microspheres prepared by a solvent evaporation/extraction process. , 1997, Biomaterials.
[25] S. Honda,et al. Common conditions for high-performance liquid chromatographic microdetermination of aldoses, hexosamines, and sialic acids in glycoproteins. , 1984, Analytical biochemistry.
[26] A. Coombes,et al. The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[27] M. Yeh,et al. Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[28] S. P. Vyas,et al. Preparation, characterization and in vitro antimicrobial activity of metronidazole bearing lectinized liposomes for intra-periodontal pocket delivery. , 2001, Die Pharmazie.
[29] A. Goyal,et al. Lectin anchored stabilized biodegradable nanoparticles for oral immunization 1. Development and in vitro evaluation. , 2006, International journal of pharmaceutics.
[30] T. Burke,et al. The Acidic Microclimate in Poly(lactide-co-glycolide) Microspheres Stabilizes Camptothecins , 1999, Pharmaceutical Research.
[31] N Hussain,et al. Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence. , 1995, Journal of drug targeting.
[32] M. Jepson,et al. Studying M cells and their role in infection. , 1998, Trends in microbiology.
[33] H. Rammensee,et al. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine , 1989, Nature.
[34] H. Marcotte,et al. Oral Microbial Ecology and the Role of Salivary Immunoglobulin A , 1998, Microbiology and Molecular Biology Reviews.
[35] P. Sansonetti,et al. M cells as ports of entry for enteroinvasive pathogens: mechanisms of interaction, consequences for the disease process. , 1999, Seminars in immunology.
[36] M. Wolf,et al. Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen. , 2003, Vaccine.
[37] E. Lavelle,et al. The identification of plant lectins with mucosal adjuvant activity , 2001, Immunology.
[38] E. Untersmayr,et al. M cell targeting with Aleuria aurantia lectin as a novel approach for oral allergen immunotherapy. , 2004, The Journal of allergy and clinical immunology.
[39] Jerry M. Lefkowitz,et al. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. , 1984, Journal of immunological methods.
[40] W. Koff,et al. Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice. , 1997, Vaccine.
[41] G. Russell-Jones,et al. Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding , 1988, The Journal of experimental medicine.
[42] G. Russell-Jones,et al. The potential use of receptor-mediated endocytosis for oral drug delivery. , 2001, Advanced drug delivery reviews.
[43] D. Volkin,et al. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres. , 2002, Journal of pharmaceutical sciences.
[44] B. Hirst,et al. Differential expression of lectin-binding sites defines mouse intestinal M-cells. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.